Combined treatment with SM934 (a novel water-soluble artemisinin analog) and testosterone inhibited proliferation and metastasis of cancers by inhibiting cathepsin K expression, which in turn inhibited Bcl-xL [5]. Here, CTSK is linked to cancer.